The pace of innovation has accelerated over the past decade, resulting in dramatically better treatments and cures for life-threatening diseases. These innovations, however, have not always reached the patients in China who need them. We will apply our R&D and commercial expertise to help Chinese patients gain earlier access to more affordable, innovative medicines.
Even as we focus intently on the needs of patients in China, we are pursuing opportunities to improve the health of patients around the globe by marrying our research-intensive company with the capabilities and talents of multinational partners.